Colitis and cancer: a tale of inflammatory cells and their cytokines

被引:17
作者
Burstein, Ezra [1 ,2 ]
Fearon, Eric R. [1 ,2 ,3 ,4 ]
机构
[1] Univ Michigan, Sch Med, Mol Mech Dis Program, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
关键词
NF-KAPPA-B; CROHNS-DISEASE; BOWEL-DISEASE; ULCERATIVE-COLITIS; MICE; NOD2; SUSCEPTIBILITY; MODEL; CARCINOGENESIS; TUMORIGENESIS;
D O I
10.1172/JC134831
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Chronic inflammatory disorders are often associated with an increased cancer risk. A particularly striking example of the chronic inflammation-cancer link is seen in inflammatory bowel disease, in which chronic colitis or persistent inflammation in the colon is associated with elevated risk of colorectal cancer. Animal models exploring the mechanisms by which inflammation increases the risk of colon cancer have shown that inflammatory cells, through the effects of the cytokines they produce, have a major role in promoting neoplastic transformation. In this issue of the JCI, Popivanova and colleagues demonstrate that TNF-alpha, through its effects on the immune system, plays a critical role in promoting neoplastic transformation in this setting (see the related article beginning on page 560). Importantly, the study also provides evidence that anti-TNF-alpha. therapies, which are currently in clinical use, may interrupt the process.
引用
收藏
页码:464 / 467
页数:4
相关论文
共 24 条
[1]
Activation of nuclear factor κB in colonic mucosa from patients with collagenous and ulcerative colitis [J].
Andresen, L ;
Jorgensen, VL ;
Perner, A ;
Hansen, A ;
Eugen-Olsen, J ;
Rask-Madsen, J .
GUT, 2005, 54 (04) :503-509
[2]
[Anonymous], SCI STKE
[3]
TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling [J].
Becker, C ;
Fantini, MC ;
Schramm, C ;
Lehr, HA ;
Wirtz, S ;
Nikolaev, A ;
Burg, J ;
Strand, S ;
Kiesslich, R ;
Huber, S ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Nishimoto, N ;
Galle, PR ;
Blessing, M ;
Rose-John, S ;
Neurath, MF .
IMMUNITY, 2004, 21 (04) :491-501
[4]
The NF-κB signaling pathway in human genetic diseases [J].
Courtois, G .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (15) :1682-1691
[5]
The c-Rel transcription factor and B-cell proliferation: a deal with the devil [J].
Gilmore, TD ;
Kalaitzidis, D ;
Liang, MC ;
Starczynowski, DT .
ONCOGENE, 2004, 23 (13) :2275-2286
[6]
Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing [J].
Girardin, SE ;
Hugot, JP ;
Sansonetti, PJ .
TRENDS IN IMMUNOLOGY, 2003, 24 (12) :652-658
[7]
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer [J].
Greten, FR ;
Eckmann, L ;
Greten, TF ;
Park, JM ;
Li, ZW ;
Egan, LJ ;
Kagnoff, MF ;
Karin, M .
CELL, 2004, 118 (03) :285-296
[8]
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations [J].
Hampe, J ;
Cuthbert, A ;
Croucher, PJP ;
Mirza, MM ;
Mascheretti, S ;
Fisher, S ;
Frenzel, H ;
King, K ;
Hasselmeyer, A ;
MacPherson, AJS ;
Bridger, S ;
van Deventer, S ;
Forbes, A ;
Nikolaus, S ;
Lennard-Jones, JE ;
Foelsch, UR ;
Krawczak, M ;
Lewis, C ;
Schreiber, S ;
Mathew, CG .
LANCET, 2001, 357 (9272) :1925-1928
[9]
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease [J].
Hugot, JP ;
Chamaillard, M ;
Zouali, H ;
Lesage, S ;
Cézard, JP ;
Belaiche, J ;
Almer, S ;
Tysk, C ;
O'Morain, CA ;
Gassull, M ;
Binder, V ;
Finkel, Y ;
Cortot, A ;
Modigliani, R ;
Laurent-Puig, P ;
Gower-Rousseau, C ;
Macry, J ;
Colombel, JF ;
Sahbatou, M ;
Thomas, G .
NATURE, 2001, 411 (6837) :599-603
[10]
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases [J].
Itzkowitz, SH ;
Harpaz, N .
GASTROENTEROLOGY, 2004, 126 (06) :1634-1648